Related Experiment Video
Updated: May 6, 2026
08:00
Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
9.9K
Exercise and Cystic Fibrosis (CF) 2.0
1Women and Children's Hospital of Buffalo.
Pediatric Exercise Science
|November 12, 2013
Summary
Regular exercise is crucial for cystic fibrosis (CF) patients, improving airway function and slowing disease progression. Physical activity is now a recommended part of standard CF care.
Area of Science:
- Pulmonary Medicine
- Exercise Physiology
- Genetics
Background:
- Exercise was recognized as safe and beneficial for cystic fibrosis (CF) patients in 1989.
- The genetic cause of CF was identified in 1989, leading to improved treatments and increased lifespan.
- Understanding of exercise limitations and benefits in CF has evolved significantly.
Purpose of the Study:
- To highlight the established safety and physiological responses to exercise in cystic fibrosis patients.
- To emphasize the role of exercise in mitigating the effects of the genetic defect in CF.
- To advocate for the integration of regular exercise into standard CF care.
Main Methods:
- Review of historical understanding of exercise in CF.
- Analysis of the impact of genetic discoveries on CF treatment and patient outcomes.
- Synthesis of current knowledge on exercise capacity and its modulation in CF.
Main Results:
- Exercise, including prescribed physical activity, can be safely performed by CF patients.
- Regular exercise plays a key role in slowing CF progression.
- Exercise modulates some effects of the CF genetic defect on airway function.
Conclusions:
- There is a consensus that regular exercise should be part of the standard care for cystic fibrosis.
- Increased understanding of exercise physiology and CF genetics supports exercise as a therapeutic strategy.
- Exercise is vital for improving quality of life and potentially extending lifespan in individuals with CF.
More Related Videos
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
707
07:04Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
Published on: February 11, 2017
18.9K
Related Concept Videos
01:24Cystic Fibrosis: Management
657
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
657
01:23Cystic Fibrosis: Pathogenesis
1.1K
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
155
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
155
01:24Chronic Obstructive Pulmonary Disease
3.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.2K
01:23Chronic Obstructive Pulmonary Disease I: Introduction
71
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
71
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.0K